Product Overview: Kamagra Kamagra
Kamagra is a sildenafil citrate-based pharmaceutical compound extensively studied for its mechanisms in erectile dysfunction research protocols. This PDE5 inhibitor demonstrates selective antagonist activity against phosphodiesterase type 5 enzymes in vascular smooth muscle tissue models. Laboratory investigations at Stroid UK Shop examine its effects on cyclic guanosine monophosphate pathways and nitric oxide signalling cascades. Research protocols evaluate vasodilation mechanisms and endothelial function modulation in controlled experimental environments. Studies investigate bioavailability profiles, metabolic pathways, and tissue distribution patterns using standardised analytical methods.
Laboratory Applications
Researchers examine Kamagra’s pharmacokinetic properties and molecular interactions with phosphodiesterase enzymes in cellular assays. Investigations focus on vascular biology, examining smooth muscle relaxation pathways and endothelial nitric oxide synthesis mechanisms. Laboratory studies analyse the compound’s effects on cardiovascular tissue responses and blood flow dynamics in experimental models. Research applications include examining drug interaction profiles with sildenafil citrate analogues and evaluating metabolic stability under various experimental conditions. Studies investigate receptor binding affinities and enzymatic inhibition kinetics using biochemical assay protocols. Comparative analyses examine efficacy profiles against reference compounds in controlled laboratory environments. Research protocols evaluate dose-response relationships and temporal pharmacodynamic effects in tissue culture systems. Investigations analyse molecular mechanisms underlying vasodilation responses and examine potential synergistic effects when studied alongside selective androgen receptor modulators and peptide compounds.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| CAS Number | 171599-83-0 |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | PDE5 inhibition studies, vascular biology |
Research Compliance
This compound is intended exclusively for in-vitro research applications and laboratory analysis. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must comply with institutional guidelines and applicable regulations governing research chemical handling and disposal protocols.
